New drugs in the treatment of drug-resistant tuberculosis in children. Experience with the use of delamanid in combination with bedaquiline

New drugs in the treatment of drug-resistant tuberculosis in children. Experience with the use of delamanid in combination with bedaquiline

OBJECTIVE: To determine the safety and effectiveness of delamanid in combination with bedaquiline in children for the treatment of multidrug-resistant tuberculosis. MATERIALS-METHODS: In 2023-2024, 18 children aged 3 to 17 years with MDR-TB were treated. Mycobacterium tuberculosis (MBT) was detected...

Full description

Saved in:
Bibliographic Details
Main Authors: Ekaterina Sokolskaya, Nadezhda Klevno, Anastasiya Samoylova, Alexey Kazakov, Anastasiya Gaida
Format: Article
Language:English
Published: Elsevier 2024-12-01
Series:Journal of Global Antimicrobial Resistance
Subjects:
multidrug-resistant tuberculosis
MDR-TB in children
bedaquiline
delamanid
Online Access:http://www.sciencedirect.com/science/article/pii/S2213716524003588
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items